2002
Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome
Heard M, Pierce A, Carson S, Buster J. Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome. Fertility And Sterility 2002, 77: 669-673. PMID: 11937113, DOI: 10.1016/s0015-0282(01)03266-6.Peer-Reviewed Original ResearchConceptsPolycystic ovary syndromeOvary syndromeSpontaneous abortionDiagnosis of PCOSAnovulatory infertility patientsUse of metforminResumption of mensesGastrointestinal-related side effectsEvidence of ovulationDosage of metforminAnovulatory patientsMetformin therapyPCOS resultsClomiphene citrateOvulation inductionPregnancy outcomesSpontaneous mensesInfertility patientsCase seriesMedian timeOvulatory responseMAIN OUTCOMESide effectsPatientsMetformin
1996
Androgen replacement therapy in women: myths and realities.
Casson P, Carson S. Androgen replacement therapy in women: myths and realities. International Journal Of Fertility And Women's Medicine 1996, 41: 412-22. PMID: 8894799.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsAndrogen replacementMenopausal womenAndrogen replacement therapyGrowth hormone axisLong-term trialsProlonged therapyAdrenal androgensTestosterone replacementReplacement therapyNatural menopauseHormone axisClinical investigationSide effectsDeficiency statesImmune systemPhysiologic levelsWomenTherapyPotential benefitsPreliminary studyReplacementMenopauseDHEAAndrogensTrials
1991
Methotrexate treatment of unruptured ectopic pregnancy: a report of 100 cases.
Stovall T, Ling F, Gray L, Carson S, Buster J. Methotrexate treatment of unruptured ectopic pregnancy: a report of 100 cases. Obstetrics And Gynecology 1991, 77: 749-53. PMID: 2014090.Peer-Reviewed Original ResearchConceptsUnruptured ectopic pregnancyEctopic pregnancyConservative surgical proceduresHCG titerPatient nosPrimary therapySurgical proceduresSide effectsPrevious ectopic pregnancyRecurrent ectopic pregnancyIdentifiable risk factorsOngoing clinical trialsCardiac activityTubal pregnancyPersistent diseaseFourth doseMedical therapyMethotrexate treatmentOutpatient protocolInvolved sideTubal patencyRisk factorsClinical trialsPregnancyPatients